Michael Bergin

Michael Bergin is an accomplished executive with extensive experience in Quality and Regulatory oversight across various sectors including pharmaceuticals, medical devices, and biologics. They have held prominent roles such as Vice President of Product Quality at Fresenius Medical Care North America, where they managed quality operations across multiple manufacturing facilities, and currently serve as the Executive Director of Quality at Verve Therapeutics, focusing on early-stage gene editing clinical trials. Michael's career spans over three decades, encompassing positions in quality assurance, compliance auditing, and strategic consulting, with a strong emphasis on fostering organizational efficiency and regulatory compliance. Michael earned a Bachelor's degree from Southern New Hampshire University and continues to lead initiatives that enhance quality systems within the industry.